Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: ZYMERON CORPORATION
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Department of the Army
Period of performance: 2023-06-30 to 2024-01-29
Current total value of award: $250000
Description: ZYMERON DHA SBIR PHASE I H231-004-0023 NOVEL AEROSOL THERAPY FOR IMMEDIATE AND SUSTAINED ARDS MANAGEMENT